Printer Friendly
The Free Library
14,669,463 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

FDA allows Base Ten Systems to immediately market Prenval 1; first product of this type to come before the FDA for clearance.


TRENTON, N.J.--(BUSINESS WIRE)--Sept. 21, 1995--Base Ten Systems Inc. (Nasdaq NM: BASEA BASEA Boston Area Solar Energy Association ) announced today that it has received formal written notification from the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 allowing the company to immediately begin marketing PRENVAL(TM) 1 as described in the company's 510(k) premarket notification.

PRENVAL(TM) 1 is a software computer program to assist in the database management, calculation of Multiple of the Median (MoM) and generation of reports from quantitative measurement of Alpha-fetoprotein (AFP (1) (AppleTalk Filing Protocol) The file sharing protocol used in an AppleTalk network. In order for non-Apple networks to access data in an AppleShare server, their protocols must translate into the AFP language. See file sharing protocol. ).

Maternal serum Alpha-fetoprotein (MSAFP MSAFP Maternal Serum Alpha-Fetoprotein ) and amniotic fluid Alpha-fetoprotein (AFAFP) screening for the detection of fetal abnormalities and abnormal pregnancies have been used for over twenty years by obstetricians and geneticists. Abnormal MSAFP and AFAFP levels are associated with a number of fetal abnormalities, including open neural tube defects Neural tube defects
A group of birth defects that affect the backbone and sometimes the spinal chord.

Mentioned in: Birth Defects
 such as spina bifida and anencephaly anencephaly /an·en·ceph·a·ly/ (an?en-sef´ah-le) congenital absence of the cranial vault, with the cerebral hemispheres completely missing or reduced to small masses.anencephal´ic

an·en·ceph·a·ly
n.
, congenital nephrosis nephrosis (nəfrō`səs), kidney disease characterized by lesions of the epithelial lining of the renal tubules, resulting in marked disturbance in the filtration function and the consequent appearance of large amounts of protein (albumin) , gastrointestinal tract abnormalities, and other gestational defects.

Mike Kranzler, chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  said "We are delighted to finally have reached the point where we can market and sell PRENVAL(TM) 1, the first product of this type to come before the FDA for clearance. We believe our success in this new software regulatory environment is based on the thoroughness of our design, the in depth documentation we provided, and the development of this product as if it were of the highest risk.

"Our plans are to commence the implementation of our marketing and sales plan by informing clinical and laboratory facilities across the nation that this product is now available and to expand the number of forms in which it can be offered. PRENVAL(TM) 1 is the first of a family of products we intend to develop using the same safety critical software techniques that characterize all of our Medical Technology products. It represents an outstanding example of a commercial product generated from the successful transition of a defense technology culture.

"It is important to note that PRENVAL(TM) 1 is built from a standard proprietary software structure. For other medical applications, we will be able to use the same structure to further serve the health care community."

Base Ten Systems Inc. is a diversified technology company dedicated to providing safety critical products to the medical, manufacturing and weapons industries.

CONTACT: Base Ten Systems Inc., Trenton

Edward J. Klinsport, 609/586-7010

or

Strategic Growth International Inc.

Richard E. Cooper, 516/829-7111
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 21, 1995
Words:384
Previous Article:Anchor Financial Corp. announces plans for expansion to Wilmington.
Next Article:OSCAR GRUSS & SON ADDS ANALYST NICOLE SCHMIDT TO STRENGTHEN HIGH-TECH RESEARCH COVERAGE.
Topics:



Related Articles
FDA arouses concerns on colorants. (Food and Drug Administration)
Who will regulate the regulators? If you make a mistake, shouldn't you own up? Not if you're the FDA, EPA, or FTC. (Environmental Protection Agency;...
Base Ten announces contract with Miles; first U.S. contract for Pharmasyst(TM).
Base Ten Annual Report.
Base Ten's Premarket Approval application to be reviewed by FDA panel on March 31, 1995.
FDA advisory votes 5 to 3 against Base TEN's Prenval(TM) I approval; vote reflects conflict between FDA and panel members, but PMA remains under...
PRENVAL 1 to receive FDA clearance as a medical device.
Base Ten investor has 14% stake in common stock.
BASE TEN ANNOUNCES THIRD QUARTER RESULTS; Over 20% of Sales Derived from Medical Products.
Base Ten allowed Prenval technology patent; Computerized diagnostic engine intended for many disorders.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles